Cat.#: ACPP-1119
| Despition | CD56 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1737 | Human NCALD Protein (AC1737) | 5 µg | inquiry |
| ACPP-1254 | Luteinizing Hormone Blocking Peptide (AC1254) | 250 µg | inquiry |
| ACPP-1604 | Human GSK3B Protein (AC1604) | 2 µg | inquiry |
| ACPP-1371 | Ki67 Blocking Peptide (AC1371) | 250 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1527 | Mouse ANTXR2 Protein (AC1527) | 1 µg | inquiry |
| ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
| ACPP-1105 | Human Leptin Protein (AC1105) | 200 µg | inquiry |
| ACPP-1830 | Human SDC1 Protein (AC1830) | 5 µg | inquiry |
| ACPP-1364 | Estrogen Receptor alpha Blocking Peptide (AC1364) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.